-
Buffets, baristas, but no briefings: journalists frozen out of Iran talks
-
McIlroy's Masterpiece remains the buzz at Augusta
-
Sinner brushes past Zverev to reach Monte Carlo final
-
Arsenal suffer major blow in Premier League title charge
-
UK puts Chagos handover deal in 'deep freeze' after Trump criticism
-
In Europe first, Netherlands to allow Teslas to self-drive
-
Sabrina Carpenter transforms Coachella into her own 'Sabrinawood'
-
Iran, Lebanon bore brunt of missiles and drones launched during war
-
Iran envoys meet Pakistani PM ahead of US talks
-
UK to shelve Chagos handover after Trump criticism
-
Somalia president congratulates World Cup-bound referee Omar Artan
-
Vance in Islamabad for Iran talks overshadowed by mutual mistrust
-
After Artemis II, NASA looks to SpaceX, Blue Origin for Moon landings
-
Benin leans into painful past to attract tourists
-
Britain storm into Billie Jean King Cup finals with Australia thumping
-
Russia and Ukraine set to begin Easter truce
-
Hawks clinch NBA playoff berth with win over Cavs
-
Trump administration reveals plans for massive Washington arch
-
Carney poised to win Canada majority but affordability pressure looms
-
Artemis II lunar mission draws flood of conspiracy theories
-
Extra time at Augusta helps McIlroy make Masters magic
-
Panic buttons, undercover cops: How Peru bus drivers try to stay safe
-
Iran, US to hold peace talks overshadowed by mutual mistrust
-
Artemis II astronauts return to Earth, capping historic Moon mission
-
Small US farm copes with fuel hikes from Mideast war
-
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
-
McIlroy seizes 36-hole record six-shot Masters lead with epic finish
-
Iranian delegation in Pakistan for talks with US, Vance en route
-
Rory McIlroy seizes Masters record six-stroke lead after 36 holes
-
Djibouti leader claims sixth straight term
-
Trump vows to boost Hungary economy if Orban wins vote
-
Mythos AI alarm bells: Fair warning or marketing hype?
-
De Zerbi 'not surprised' by backlash from Spurs fans over Greenwood
-
Marseille boost hopes of Champions League return, Monaco suffer heavy defeat
-
Frustrated Scheffler finds water hazards at Masters
-
Swing and miss: Ichiro statue reveal goes awry as bat snaps
-
China's Li flushes toilet trouble at Masters
-
Stocks up, oil down over week on guarded optimism for Iran
-
Real Madrid title hopes dented by Girona draw
-
Malen hits hat-trick as Roma rebound against declining Pisa
-
Playoff loss to McIlroy not motivating 'nearly man' Rose
-
Lebanon says Israel talks set for Tuesday in US
-
West Ham sink Wolves to climb out of relegation zone as Spurs slip into bottom three
-
OpenAI CEO's California home hit by Molotov cocktail, man arrested
-
Holders Italy and Ukraine make strong starts in BJK Cup as USA trail
-
Top takeaways from the Artemis II mission
-
McIlroy seizes command at the turn at Masters
-
Hatton jumps into Masters hunt with stunning 66
-
African charity sues Prince Harry for defamation
-
Fury happy to be the 'hunter' on return to ring
Medical Care Technologies Inc. (OTC PINK:MDCE) Marches Forward with Breakthrough Patent-Pending AI Healthcare Solutions using Smart Devices
A very unique multi-vertical health AI engine capable of early detection for mental health, wound infection, skin cancer, and disease risk-all through a smartphone
MESA, ARIZONA / ACCESS Newswire / November 10, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major technological milestone with the development of its patent-pending AI health platform (U.S. Provisional Patent Application No. 63/854,935), engineered to bring real-time diagnostic intelligence directly to smartphones. This system represents a breakthrough in mobile health screening by enabling early detection of high-risk medical conditions-without requiring specialized hardware, clinical visits, or expensive imaging devices.

Built on advanced deep learning, temporal image analysis, and affective computing, MDCE's platform is designed to identify early health indicators with precision previously limited to clinical environments. The Company is actively developing four core AI verticals-mental health screening, wound monitoring, skin cancer detection, and predictive health risk analysis-targeting rapidly growing markets valued collectively in the trillions.
"Our mission is to make proactive health screening not only accessible, but effortless," said Marshall Perkins, CEO of Medical Care Technologies Inc. "If we can give people the ability to detect risk earlier-whether it's melanoma, infection, or silent mental health decline-then we unlock a new era of preventative, data-driven healthcare. This is not the future of diagnostics; it is the beginning of a new standard of care delivered through everyday technology."
A Scalable AI Ecosystem Targeting Critical Healthcare Gaps
MDCE's multi-vertical platform aims to transform how patients approach preventative care:
AI Mental Health Screening
Uses high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to identify early signs of anxiety, depression, and PTSD-supporting a digital mental health market already exceeding $400 billion globally.AI Wound Monitoring
Analyzes sequential imaging for infection risk, tissue deterioration, and healing progression-impacting the global chronic wound care market projected to surpass $30 billion by 2030.AI Skin Cancer Screening
Employs full-body lesion mapping, 3D indexing, and temporal skin-change detection to enable population-scale early melanoma awareness within a $15+ billion dermatology diagnostics market.AI Health Risk Estimator
Uses facial biometrics, tonal gradient analysis, and multimodal AI to predict disease predisposition and longevity risk-aligning with the rapidly expanding $4 trillion preventative and precision health sector.
MDCE expects to release its first integrated beta consumer app in 2026, marking the Company's transition into commercial deployment.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK:MDCE) is a next-generation healthcare technology company developing AI-powered diagnostic and preventative health solutions designed to make early health awareness accessible worldwide. Through proprietary deep learning models and patent-pending mobile screening technology, the Company is building a scalable ecosystem capable of transforming smartphones into powerful diagnostic tools for consumers, providers, and payers. MDCE's mission is to redefine how and where healthcare begins-by empowering individuals to detect risk earlier and make informed decisions that improve long-term health outcomes.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations, estimates, forecasts, and projections and are not guarantees of future performance. These statements may include words such as "anticipate," "expect," "intend," "plan," "believe," "potential," "may," "will," "should," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to product development timelines, regulatory considerations, market adoption, competitive conditions, and general economic factors. Medical Care Technologies Inc. undertakes no obligation to update any forward-looking statements except as required by applicable law.
Contact:
Investor Relations
Medical Care Technologies Inc.
[email protected]
Website: www.mdcestock.com
SOURCE: Medical Care Technologies, Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
F.Wilson--AT